ABCC2 and Cholestatic liver disease: As already stated, CAB plasma levels could be altered through its affinity to MRP2 transporter and it is conceivable to investigate situations, which could lead to alterations in MRP2 expression, like cholestatic liver diseases [63,64,65], based on the presented model.